Ligand Pharmaceuticals | LGND - Ebit





Ebit Alterar Data
Agenus USD 15.05M 656K 2026-03
Amgen USD 4.68B 65M 2026-09
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -154.34M 13.08M 2026-06
Baxter International USD 314M 38M 2026-09
Bristol-Myers Squibb USD 255M 44M 2026-09
Eli Lilly USD 13.09B 635M 2026-09
Enanta Pharmaceuticals USD -23.54M 6.31M 2024-12
Enviri Corporation USD -35.28M 61.58M 2025-12
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Glaxosmithkline GBP 2.15B 157M 2026-09
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -81.83M 19.48M 2026-09
Intrexon USD -26.3M 2.91M 2024-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Ligand Pharmaceuticals USD 54.53M 2.1M 2026-09
MacroGenics USD -65.25M 33.36M 2026-06
Merck USD 7.33B 6.49B 2026-09
Pacira USD 2.57B 2.56B 2026-09
Pfizer USD 4.85B 5.03B 2026-09
Rigel Pharmaceuticals USD 447K 1.52M 2024-06
Veracyte USD 18.02M 5.94M 2026-09